North America Oligonucleotide Cdmo Market Size & Outlook
Related Markets
North America oligonucleotide cdmo market highlights
- The North America oligonucleotide cdmo market generated a revenue of USD 328.5 million in 2024.
- The market is expected to grow at a CAGR of 14.8% from 2025 to 2033.
- In terms of segment, contract manufacturing was the largest revenue generating service in 2024.
- Contract Development is the most lucrative service segment registering the fastest growth during the forecast period.
- Country-wise, U.S. is expected to register the highest CAGR from 2025 to 2033.
North America data book summary
| Market revenue in 2024 | USD 328.5 million |
| Market revenue in 2033 | USD 1,129.2 million |
| Growth rate | 14.8% (CAGR from 2025 to 2033) |
| Largest segment | Contract manufacturing |
| Fastest growing segment | Contract Development |
| Historical data covered | 2021 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Contract Manufacturing, Contract Development |
Other key industry trends
- In terms of revenue, North America region accounted for 36.0% of the global oligonucleotide cdmo market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 784.0 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oligonucleotide CDMO Market Scope
Oligonucleotide CDMO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| STA Pharmaceutical | View profile | 5001-10000 | Shanghai, Shanghai, China, Asia | https://www.stapharma.com |
| Bachem | View profile | 501-1000 | Bubendorf, Basel-Landschaft, Switzerland, Europe | https://www.bachem.com/ |
| Curia Global, Inc. | View profile | - | - | - |
| Aurigene Pharmaceutical Services Ltd. | View profile | - | - | - |
| Creative Peptides | View profile | 1-10 | New York, New York, United States, North America | http://www.creative-peptides.com/index.html |
| CordenPharma | View profile | 5001-10000 | Plankstadt, Baden-Wurttemberg, Germany, Europe | http://cordenpharma.com |
| SYLENTIS | View profile | 11-50 | Madrid, Madrid, Spain, Europe | http://www.sylentis.com |
| Euroapi SA | View profile | 3326 | 15 rue Traversiere, Paris, France, 75012 | https://www.euroapi.com |
| PolyPeptide Group AG | View profile | 1273 | Neuhofstrasse 24, Baar, Zug, Switzerland, 6340 | https://www.polypeptide.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
North America oligonucleotide cdmo market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oligonucleotide cdmo market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 72.24% in 2024. Horizon Databook has segmented the North America oligonucleotide cdmo market based on contract manufacturing, contract development covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to North America oligonucleotide cdmo market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of North America oligonucleotide cdmo market databook
-
Our clientele includes a mix of oligonucleotide cdmo market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the North America oligonucleotide cdmo market , including forecasts for subscribers. This continent databook contains high-level insights into North America oligonucleotide cdmo market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
North America oligonucleotide cdmo market size, by country, 2021-2033 (US$M)
North America Oligonucleotide CDMO Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
